mRNA COVID-19 Vaccines — BioNTech/Pfizer and Moderna (2020)

Developed in under a year based on decades of work by Katalin Karikó and Drew Weissman, the BioNTech/Pfizer and Moderna mRNA vaccines demonstrated 95% efficacy and were administered to billions of people, proving a revolutionary new vaccine platform that can be rapidly adapted to emerging threats.